Vaccines for human fungal diseases: close but still a long way to go

Related Experiment Video

Updated: Nov 15, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.2K

Lorena V N Oliveira1, Ruiying Wang1, Charles A Specht1

  • 1Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

NPJ Vaccines
|March 4, 2021
PubMed

Insights

Developing effective fungal vaccines is crucial due to the high burden of human fungal infections. Research shows promise with various vaccine types in mouse models, with some advancing to human trials, but challenges remain for licensed products.

Area of Science:

  • Mycology
  • Vaccinology
  • Infectious Diseases

Background:

  • Human fungal infections pose a significant global health burden.
  • Currently, no approved fungal vaccines are available for at-risk populations.
  • Life-threatening mycoses are commonly caused by Candida, Cryptococcus, and Aspergillus species.

Purpose of the Study:

  • To review the progress and challenges in developing efficacious fungal vaccines.
  • To highlight advancements in vaccine strategies against common fungal pathogens.
  • To discuss the potential of broad-spectrum fungal vaccines.

Main Methods:

  • Review of existing research on fungal vaccine development.
  • Analysis of preclinical (mouse studies) and clinical trial data.
  • Evaluation of different vaccine platforms including live-attenuated, killed, subunit, and nucleic acid vaccines.
  • Investigation of novel adjuvants and common antigen targets.

Main Results:

  • Protection against Candida, Cryptococcus, and Aspergillus achieved in mouse models using various vaccine formulations.
  • Encouraging results from live-attenuated, killed fungi, crude extracts, subunit, and nucleic acid vaccines.
  • Development of novel adjuvants to enhance immune responses against fungi.
  • Candidate vaccines targeting conserved fungal antigens show potential for broad-spectrum protection.
  • Three fungal vaccines have progressed to human clinical trials.

Conclusions:

  • Significant progress has been made in fungal vaccine research, with promising preclinical and early clinical data.
  • Various vaccine approaches, including novel adjuvants and broad-spectrum antigens, are under investigation.
  • Despite advancements, substantial obstacles must be overcome to achieve licensed human fungal vaccines.
  • The development of effective fungal vaccines remains a critical unmet medical need.

More Related Videos

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

16.8K
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

5.6K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
647
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
619
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
256
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
589
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K